488 related articles for article (PubMed ID: 32141497)
1. 20(S)-ginsenoside Rh2 as agent for the treatment of LMN-CRC via regulating epithelial-mesenchymal transition.
Yuan Y; Wang J; Xu M; Zhang Y; Wang Z; Liang L; Sun P
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32141497
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
3. Ginsenoside Rh2 induces apoptosis and inhibits epithelial-mesenchymal transition in HEC1A and Ishikawa endometrial cancer cells.
Kim JH; Kim M; Yun SM; Lee S; No JH; Suh DH; Kim K; Kim YB
Biomed Pharmacother; 2017 Dec; 96():871-876. PubMed ID: 29078265
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Rb2 inhibits epithelial-mesenchymal transition of colorectal cancer cells by suppressing TGF-β/Smad signaling.
Dai G; Sun B; Gong T; Pan Z; Meng Q; Ju W
Phytomedicine; 2019 Mar; 56():126-135. PubMed ID: 30668333
[TBL] [Abstract][Full Text] [Related]
5. The anti-metastatic effect of ginsenoside Rb2 in colorectal cancer in an EGFR/SOX2-dependent manner.
Phi LTH; Wijaya YT; Sari IN; Yang YG; Lee YK; Kwon HY
Cancer Med; 2018 Nov; 7(11):5621-5631. PubMed ID: 30264477
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rg3 inhibits epithelial-mesenchymal transition (EMT) and invasion of lung cancer by down-regulating FUT4.
Tian L; Shen D; Li X; Shan X; Wang X; Yan Q; Liu J
Oncotarget; 2016 Jan; 7(2):1619-32. PubMed ID: 26636541
[TBL] [Abstract][Full Text] [Related]
7. JianPi JieDu Recipe Inhibits Epithelial-to-Mesenchymal Transition in Colorectal Cancer through TGF-
Liu X; Ji Q; Deng W; Chai N; Feng Y; Zhou L; Sui H; Li C; Sun X; Li Q
Biomed Res Int; 2017; 2017():2613198. PubMed ID: 28299321
[TBL] [Abstract][Full Text] [Related]
8. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside 20(S)-Rh2 exerts anti-cancer activity through targeting IL-6-induced JAK2/STAT3 pathway in human colorectal cancer cells.
Han S; Jeong AJ; Yang H; Bin Kang K; Lee H; Yi EH; Kim BH; Cho CH; Chung JW; Sung SH; Ye SK
J Ethnopharmacol; 2016 Dec; 194():83-90. PubMed ID: 27566200
[TBL] [Abstract][Full Text] [Related]
10. Ginsenoside Rg3 Inhibits Migration and Invasion of Nasopharyngeal Carcinoma Cells and Suppresses Epithelial Mesenchymal Transition.
Wang D; Wu C; Liu D; Zhang L; Long G; Hu G; Sun W
Biomed Res Int; 2019; 2019():8407683. PubMed ID: 30915362
[TBL] [Abstract][Full Text] [Related]
11. In vitro anticancer activities of osthole against renal cell carcinoma cells.
Liu L; Mao J; Wang Q; Zhang Z; Wu G; Tang Q; Zhao B; Li L; Li Q
Biomed Pharmacother; 2017 Oct; 94():1020-1027. PubMed ID: 28810525
[TBL] [Abstract][Full Text] [Related]
12. MSC-Derived exosomes suppress colorectal cancer cell proliferation and metastasis via miR-100/mTOR/miR-143 pathway.
Jahangiri B; Khalaj-Kondori M; Asadollahi E; Purrafee Dizaj L; Sadeghizadeh M
Int J Pharm; 2022 Nov; 627():122214. PubMed ID: 36152993
[TBL] [Abstract][Full Text] [Related]
13. (20S)G-Rh2 Inhibits NF-κB Regulated Epithelial-Mesenchymal Transition by Targeting Annexin A2.
Wang YS; Li H; Li Y; Zhang S; Jin YH
Biomolecules; 2020 Mar; 10(4):. PubMed ID: 32244350
[TBL] [Abstract][Full Text] [Related]
14. Ginsenoside 20(S)-Rh2 exerts anti-cancer activity through the Akt/GSK3β signaling pathway in human cervical cancer cells.
Shi X; Yang J; Wei G
Mol Med Rep; 2018 Mar; 17(3):4811-4816. PubMed ID: 29363731
[TBL] [Abstract][Full Text] [Related]
15. Isorhamnetin inhibited migration and invasion via suppression of Akt/ERK-mediated epithelial-to-mesenchymal transition (EMT) in A549 human non-small-cell lung cancer cells.
Luo W; Liu Q; Jiang N; Li M; Shi L
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31467176
[TBL] [Abstract][Full Text] [Related]
16. PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway.
Chen J; Yuan W; Wu L; Tang Q; Xia Q; Ji J; Liu Z; Ma Z; Zhou Z; Cheng Y; Shu X
Oncotarget; 2017 Feb; 8(6):9961-9973. PubMed ID: 28035069
[TBL] [Abstract][Full Text] [Related]
17. NUBPL, a novel metastasis-related gene, promotes colorectal carcinoma cell motility by inducing epithelial-mesenchymal transition.
Wang Y; Wu N; Sun D; Sun H; Tong D; Liu D; Pang B; Li S; Wei J; Dai J; Liu Y; Bai J; Geng J; Fu S; Jin Y
Cancer Sci; 2017 Jun; 108(6):1169-1176. PubMed ID: 28346728
[TBL] [Abstract][Full Text] [Related]
18. Cuban Brown Propolis Interferes in the Crosstalk between Colorectal Cancer Cells and M2 Macrophages.
Frión-Herrera Y; Gabbia D; Scaffidi M; Zagni L; Cuesta-Rubio O; De Martin S; Carrara M
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32660099
[TBL] [Abstract][Full Text] [Related]
19. The regulatory effects of metformin on the [SNAIL/miR-34]:[ZEB/miR-200] system in the epithelial-mesenchymal transition(EMT) for colorectal cancer(CRC).
Wang Y; Wu Z; Hu L
Eur J Pharmacol; 2018 Sep; 834():45-53. PubMed ID: 30017802
[TBL] [Abstract][Full Text] [Related]
20. Anti-Tumor Effects of Paeoniflorin on Epithelial-To-Mesenchymal Transition in Human Colorectal Cancer Cells.
Zhang JW; Li LX; Wu WZ; Pan TJ; Yang ZS; Yang YK
Med Sci Monit; 2018 Sep; 24():6405-6413. PubMed ID: 30208371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
